US2020108148A1PendingUtilityA1
Formulaton of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
Est. expiryMay 30, 2025(expired)· nominal 20-yr term from priority
A61K 36/9066A61K 47/46A61K 9/0053A61K 31/12
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medicinal composition useful for the treatment of head and neck cancer premalignant lesions. The composition includes a curcuminoid mixture and an essential oil of turmeric. The curcuminoid mixture consists of curcumin, demethoxycurcumin and bisdemethoxycurcumin. The essential oil of turmeric includes about 45% ar-turmerone. The weight ratio of curcuminoid mixture to essential oil of turmeric ranges from about 1:3 to about 99:1. Methods of preparation of the composition is provide. Methods of treatment of head and neck cancer premalignant lesions by oral administration is provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition for enhanced bioavailability of curcumin, the composition comprising a curcuminoid mixture and an essential oil of turmeric, the curcuminoid mixture consisting of curcumin, demethoxycurcumin and bisdemethoxycurcumin, the essential oil of turmeric comprising about 20% ar-turmerone to about 60% ar-turmerone, and wherein a weight ratio of the curcuminoid mixture to the essential oil of turmeric ranges from about 1:3 to about 99:1.
2 . The composition for enhanced bioavailability of claim 1 , wherein an enhancement of bioavailability of curcumin is at least 2 fold.
3 . The composition for enhanced bioavailability of claim 1 , wherein the weight ratio of the curcuminoid mixture to the essential oil of turmeric is about 12:1.Join the waitlist — get patent alerts
Track US2020108148A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.